Target Name: MIR548C
NCBI ID: G693129
Review Report on MIR548C Target / Biomarker Content of Review Report on MIR548C Target / Biomarker
MIR548C
Other Name(s): microRNA 548c | MIRN548C | hsa-miR-548c-3p | hsa-mir-548c | hsa-miR-548c-5p | MicroRNA 548c

MIR548c: A Non-Coding RNA Molecule Regulating Cell Cycle Progression, Apoptosis and Inflammation

MicroRNA (miRNA) 548c is a non-coding RNA molecule that plays a crucial role in various biological processes in the cell. It is a key regulator of gene expression, and is often involved in the control of cell cycle progression, apoptosis, and inflammation . MIR548c is a potential drug target and biomarker, and is currently being targeted by researchers for the development of new treatments for various diseases.

MIR548c is a member of the miRNA family, which are small non-coding RNAs that are involved in the regulation of gene expression. These RNAs are derived from microRNAs, which are small RNA molecules that are derived from RNA polymerase II. MIR548c is a non -coding RNA molecule that contains 19 amino acid residues and has a calculated molecular weight of 23.9 kilodalton (KDa).

MIR548c is expressed in various tissues and cells throughout the body, and is involved in the regulation of gene expression in many different biological processes. One of the well-known functions of MIR548c is its role in cell cycle progression. MIR548c is a regulator of the G1/S transition, which is the stage of cell cycle where the cell prepares for cell division. During the G1/S transition, MIR548c helps to regulate the conversion of the S phase to the G2/M phase, which is the stage of cell cycle where the cell prepares for cell division.

MIR548c is also involved in the regulation of apoptosis, which is the process by which cells die. During apoptosis, MIR548c helps to regulate the production of pro-inflammatory cytokines, which are involved in the process of cell death. Additionally, MIR548c is involved in the regulation of inflammation, and is thought to play a role in the development of various inflammatory diseases.

MIR548c is also a potential drug target, and is being targeted by researchers for the development of new treatments for various diseases. One of the main reasons for targeting MIR548c is its involvement in the regulation of cell cycle progression, apoptosis, and inflammation. By targeting MIR548c, researchers hope to be able to develop new treatments for diseases such as cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its potential as a drug target, MIR548c is also being studied as a biomarker. The ability to study MIR548c using techniques such as qRT-PCR, RNA sequencing, and mass spectrometry has allowed researchers to gain new insights into its role in various biological processes. By studying MIR548c in different organisms and under various conditions, researchers have been able to determine its function in the regulation of cell cycle progression, apoptosis, and inflammation.

Overall, MIR548c is a non-coding RNA molecule that plays a crucial role in various biological processes in the cell. As a potential drug target and biomarker, MIR548c is currently being targeted by researchers for the development of new treatments for various diseases. Further research is needed to fully understand the role of MIR548c in the regulation of cell cycle progression, apoptosis, and inflammation.

Protein Name: MicroRNA 548c

The "MIR548C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR548C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR548D1 | MIR548D2 | MIR548E | MIR548F1 | MIR548F2 | MIR548F3 | MIR548F4 | MIR548F5 | MIR548G | MIR548H1 | MIR548H2 | MIR548H3 | MIR548H4 | MIR548H5 | MIR548I1 | MIR548I2 | MIR548I3 | MIR548I4 | MIR548J | MIR548K | MIR548L | MIR548M | MIR548N | MIR548O | MIR548O2 | MIR548P | MIR548Q | MIR548S | MIR548T | MIR548U | MIR548V | MIR548W | MIR548X | MIR548Y | MIR549A | MIR550A1 | MIR550A2 | MIR550A3 | MIR550B1 | MIR550B2 | MIR551A | MIR551B | MIR552 | MIR553 | MIR554 | MIR555 | MIR556 | MIR557 | MIR5571 | MIR5572 | MIR5579 | MIR558 | MIR5580 | MIR5581 | MIR5582 | MIR5583-1 | MIR5584 | MIR5585 | MIR5586 | MIR5587 | MIR5588 | MIR5589 | MIR559 | MIR5590 | MIR5591 | MIR561 | MIR562 | MIR563 | MIR564 | MIR566 | MIR567 | MIR568 | MIR5680 | MIR5681A | MIR5681B | MIR5682 | MIR5683 | MIR5684 | MIR5685 | MIR5687 | MIR5688 | MIR5689 | MIR569 | MIR5690 | MIR5691 | MIR5692A1 | MIR5692A2 | MIR5692B | MIR5692C1 | MIR5692C2 | MIR5693 | MIR5694 | MIR5695 | MIR5696 | MIR5697 | MIR5698 | MIR5699 | MIR570 | MIR5700 | MIR5701-1